Haleon Cuts 2026 Organic Revenue Growth Guidance to Around 2.5%
Haleon lowered its 2026 organic revenue growth outlook to around 2.5%, from 3% to 5%. Third-quarter organic revenue growth was 2.6%, below the company’s expectations, with price up 2.1% and volume/mix up 0.5%.
The company now expects 2026 organic revenue growth of around 2.5%, down from previous guidance of 3% to 5%.In the three months to September end, organic revenue growth was 2.6%, below the company’s expectations, with price up 2.1% and volume/mix up 0.5%.The maker of Sensodyne and Panadol hailed co…